Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Comments

Loading...

Direxion Daily Pharmaceutical & Medical Bull 3X Shares Stock News

PILLARCA

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$12.41

-0.02-0.16%

Last update: Dec 15, 11:57 AM

News

Holdings Dividends Short Interest

Latest Direxion Daily Pharmaceutical & Medical Bull 3X Shares News | ARCA:PILL | Benzinga

Get the latest news on Direxion Daily Pharmaceutical & Medical Bull 3X Shares stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Direxion Daily Pharmaceutical & Medical Bull 3X Shares performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, November 12, 2025

Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
Rishabh Mishra

Monday, September 29, 2025

Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
Rishabh Mishra

Monday, September 08, 2025

Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing
Rishabh Mishra

Friday, August 01, 2025

Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'
Rishabh Mishra

Wednesday, July 16, 2025

Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'
Rishabh Mishra

Friday, July 11, 2025

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Rishabh Mishra

Friday, June 20, 2025

Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
Rishabh Mishra

Monday, May 19, 2025

Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
Rishabh Mishra

Friday, April 11, 2025

Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Rishabh Mishra

Thursday, April 15, 2021

3 Pharmaceutical ETFs That Could Be Due For A Rebound
Mark Putrino

Thursday, October 15, 2020

Heading Into The Election, Traders Are Still Betting On Tech
Direxion

Tuesday, May 19, 2020

In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs
Direxion

Sunday, February 23, 2020

~150 Prescription Drugs, Including Antibiotics, Generics, Some Branded Drugs without Alternatives Face Shortages Due to Coronavirus
Charles Gross

Monday, February 10, 2020

3 Leveraged Healthcare ETFs Soaring This Month
ETF Professor

Thursday, January 16, 2020

Expert: 'I've had far fewer defensive conversations than I would have expected' About The Market
Jaycee Tenn

Tuesday, July 23, 2019

With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF
ETF Professor

Tuesday, February 26, 2019

It Could Be Time For This Pharma ETF
ETF Professor

Friday, February 01, 2019

Pharma Catches Another Case Of M&A Fever
Chris Dier-Scalise

Friday, July 27, 2018

Having Fun With Pharma ETFs
ETF Professor

Wednesday, November 29, 2017

A Lazarus Act For This Pharma ETF
Benzinga
CUREs For The Ordinary December Trade
Benzinga

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved